Strides Pharma Science Limited STAR.NS Stock
Strides Pharma Science Limited Price Chart
Strides Pharma Science Limited STAR.NS Financial and Trading Overview
| Strides Pharma Science Limited stock price | 843.5 INR |
| Previous Close | 402.2 INR |
| Open | 403.75 INR |
| Bid | 405.75 INR x 0 |
| Ask | 405.9 INR x 0 |
| Day's Range | 402.65 - 410.8 INR |
| 52 Week Range | 268.15 - 413.75 INR |
| Volume | 509.73K INR |
| Avg. Volume | 666.41K INR |
| Market Cap | 36.81B INR |
| Beta (5Y Monthly) | 0.637671 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -16.8 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 5, 2021 |
| 1y Target Est | 436.5 INR |
STAR.NS Valuation Measures
| Enterprise Value | 62.29B INR |
| Trailing P/E | N/A |
| Forward P/E | 17.090527 |
| PEG Ratio (5 yr expected) | -0.49 |
| Price/Sales (ttm) | 0.997914 |
| Price/Book (mrq) | 1.6516448 |
| Enterprise Value/Revenue | 1.689 |
| Enterprise Value/EBITDA | 14.48 |
Trading Information
Strides Pharma Science Limited Stock Price History
| Beta (5Y Monthly) | 0.637671 |
| 52-Week Change | 30.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 413.75 INR |
| 52 Week Low | 268.15 INR |
| 50-Day Moving Average | 353.82 INR |
| 200-Day Moving Average | 328.46 INR |
STAR.NS Share Statistics
| Avg. Volume (3 month) | 666.41K INR |
| Avg. Daily Volume (10-Days) | 1.53M INR |
| Shares Outstanding | 90.3M |
| Float | 50.72M |
| Short Ratio | N/A |
| % Held by Insiders | 34.06% |
| % Held by Institutions | 27.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.5 |
| Trailing Annual Dividend Yield | 0.37% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -5.49% |
| Operating Margin (ttm) | 5.06% |
| Gross Margin | 55.89% |
| EBITDA Margin | 11.66% |
Management Effectiveness
| Return on Assets (ttm) | 1.71% |
| Return on Equity (ttm) | -10.13% |
Income Statement
| Revenue (ttm) | 36.88B INR |
| Revenue Per Share (ttm) | 409.37 INR |
| Quarterly Revenue Growth (yoy) | 13.90% |
| Gross Profit (ttm) | 20.62B INR |
| EBITDA | 4.3B INR |
| Net Income Avi to Common (ttm) | -2212039936 INR |
| Diluted EPS (ttm) | -24.55 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.67B INR |
| Total Cash Per Share (mrq) | 40.75 INR |
| Total Debt (mrq) | 30.3B INR |
| Total Debt/Equity (mrq) | 139.43 INR |
| Current Ratio (mrq) | 1.085 |
| Book Value Per Share (mrq) | 245.755 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 444.11M INR |
| Levered Free Cash Flow (ttm) | 3B INR |
Profile of Strides Pharma Science Limited
| Country | India |
| State | N/A |
| City | Bengaluru |
| Address | Strides House |
| ZIP | 560076 |
| Phone | 91 80 6784 0000 |
| Website | https://www.strides.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company has a strategic partnership with Orbicular Pharmaceutical Technologies Private Limited to develop, manufacture, and commercialize nasal sprays. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Q&A For Strides Pharma Science Limited Stock
What is a current STAR.NS stock price?
Strides Pharma Science Limited STAR.NS stock price today per share is 843.5 INR.
How to purchase Strides Pharma Science Limited stock?
You can buy STAR.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Strides Pharma Science Limited?
The stock symbol or ticker of Strides Pharma Science Limited is STAR.NS.
Which industry does the Strides Pharma Science Limited company belong to?
The Strides Pharma Science Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Strides Pharma Science Limited have in circulation?
The max supply of Strides Pharma Science Limited shares is 91.9M.
What is Strides Pharma Science Limited Price to Earnings Ratio (PE Ratio)?
Strides Pharma Science Limited PE Ratio is now.
What was Strides Pharma Science Limited earnings per share over the trailing 12 months (TTM)?
Strides Pharma Science Limited EPS is -16.8 INR over the trailing 12 months.
Which sector does the Strides Pharma Science Limited company belong to?
The Strides Pharma Science Limited sector is Healthcare.
Strides Pharma Science Limited STAR.NS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}